Paracetamol-caffeine Export Market Intelligence: India's 31 Suppliers Shipping to 24 Countries — TransData Nexus 2026

Q: Who are the top paracetamol-caffeine exporters from India?

The top paracetamol-caffeine exporters from India are: 1. BASE PHARMACY INDIA — $666.7K (48.2% market share); 2. COMBITIC GLOBAL CAPLET PRIVATE LIMITED — $108.3K (7.8% market share); 3. RONAK EXIM PRIVATE LIMITED — $90.0K (6.5% market share); 4. SHALINA LABORATORIES PRIVATE LIMITED — $73.6K (5.3% market share); 5. AMICO PHARMA — $60.8K (4.4% market share). Together they account for 72.2% of India's total paracetamol-caffeine export value.

Q: Which countries import paracetamol-caffeine from India?

India exports paracetamol-caffeine to 24 countries worldwide. The top importing countries are: GHANA (51.9% share, $718.3K), AFGHANISTAN (9.3% share, $128.2K), SIERRA LEONE (6.4% share, $89.0K), KENYA (6.4% share, $88.2K), SOMALIA (5.1% share, $70.6K). These five markets account for 79.1% of total export value.

Q: What is the average price of paracetamol-caffeine exports from India?

The average unit price for paracetamol-caffeine exports from India is $2.39 USD per unit, with prices ranging from $0.01 to $16.95 depending on formulation, packaging, and order volume. The total market is valued at $1.4M across 118 shipments.

Q: Which ports handle paracetamol-caffeine exports from India?

The primary ports for paracetamol-caffeine exports from India are JNPT (31.4% of shipments), JNPT/ NHAVA SHEVA SEA (11.0% of shipments), Hyderabad Air (9.3% of shipments), Chawapayal ICD (5.1% of shipments), Sonepat ICD (5.1% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of paracetamol-caffeine?

India is one of the world's leading exporters of paracetamol-caffeine due to its large base of 31 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports paracetamol-caffeine to 24 countries, demonstrating 12% global market coverage.

Q: What certifications do Indian paracetamol-caffeine exporters need?

Indian paracetamol-caffeine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import paracetamol-caffeine from India?

There are 45 registered buyers importing paracetamol-caffeine from India, spread across 24 countries. The repeat buyer rate is 64.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top paracetamol-caffeine supplier from India?

BASE PHARMACY INDIA is the leading paracetamol-caffeine exporter from India with a market share of 48.2% and total export value of $666.7K across 10 shipments. The top 5 suppliers together control 72.2% of total export value.

Suresh Sormare

Paracetamol-caffeine

India Pharmaceutical Trade Intelligence

$1.4M31 Suppliers24 CountriesHS 30049099

ExportsIndia → GHANA51.9%India → AFGHANISTAN9.3%

#1 Supplier: BASE PHARMACY #1 Buyer: SHALINA HEALTHCARE

Paracetamol Caffeine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Paracetamol-caffeine to the World

Between 2022 and 2026, India exported $1.4M worth of paracetamol-caffeine across 118 verified shipments to 24 countries — covering 12% of world markets in the Combination Drugs segment. The largest destination is GHANA (51.9%). BASE PHARMACY INDIA leads with a 48.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Paracetamol-caffeine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Paracetamol-caffeine export data snapshot — $1.4M · 31 exporters · 24 countriesTransData Nexus · Indian Customs Data

Top Paracetamol-caffeine Exporters from India

31 active exporters · Ranked by export value

View all 31 →

Top Paracetamol-caffeine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	BASE PHARMACY INDIA	$666.7K	10	1	48.2%
2	COMBITIC GLOBAL CAPLET PRIVATE LIMITED

Top Countries Importing Paracetamol-caffeine from India

24 destination markets · Ranked by import value

All 24 countries →

Top Countries Importing Paracetamol-caffeine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	GHANA	$718.3K	51.9%
2	AFGHANISTAN	$128.2K	9.3%
3	SIERRA LEONE	$89.0K	6.4%
4	KENYA	$88.2K	6.4%
5	SOMALIA	$70.6K	5.1%
6	CONGO THE DEMOCRATIC REPUBLIC OF THE	$63.2K	4.6%
7	FRANCE	$35.0K	2.5%
8	TURKMENISTAN	$33.2K	2.4%
9	CONGO	$30.7K	2.2%
10	BENIN	$27.4K	2.0%

GHANA is India's largest paracetamol-caffeine export destination, absorbing 51.9% of total exports worth $718.3K. The top 5 importing countries — GHANA, AFGHANISTAN, SIERRA LEONE, KENYA, SOMALIA — together account for 79.1% of India's total paracetamol-caffeine export value. The remaining 19 destination countries collectively receive the other 20.9%, indicating a focused distribution strategy targeting key markets.

Regulatory Landscape — Paracetamol-caffeine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, paracetamol (known as acetaminophen) combined with caffeine is commonly used for the treatment of headaches and other pain-related conditions. The FDA's Orange Book lists several approved New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs) for such combinations. For instance, an NDA for a combination of aspirin, butalbital, caffeine, and codeine phosphate capsules was approved on March 5, 1999. However, specific ANDA approvals for paracetamol-caffeine combinations are not prominently listed, indicating that while such combinations are available, they may not be as prevalent in the US market.

The regulatory pathway for these combinations involves demonstrating bioequivalence to a reference listed drug, ensuring compliance with Current Good Manufacturing Practices (cGMP), and adhering to labeling requirements that inform consumers about potential risks, especially concerning liver damage associated with acetaminophen and the stimulant effects of caffeine. Given the presence of 31 active Indian exporters, it is crucial for these entities to stay updated on FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, paracetamol-caffeine combinations are subject to stringent regulatory oversight. The European Medicines Agency (EMA) conducts periodic safety update report single assessments (PSUSAs) for such combinations. For example, a PSUSA procedure (PSUSA/00002312/202506) was initiated in March 2026, covering combinations like caffeine, codeine, paracetamol, and propyphenazone. (ema.europa.eu) These assessments ensure that the benefit-risk balance of these medicines remains favorable.

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK also monitors these combinations. In March 2015, the MHRA reviewed the promotion of Syndol Headache Relief Tablets, which contain paracetamol, codeine, and caffeine, to ensure compliance with advertising regulations. (gov.uk) Manufacturers must comply with EU Good Manufacturing Practice (GMP) guidelines, which encompass quality management, personnel, premises, equipment, documentation, production, quality control, and self-inspection.

3WHO Essential Medicines & Global Standards

Paracetamol is listed in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in basic healthcare systems. While caffeine is not listed separately, its combination with paracetamol is recognized for its enhanced analgesic effect. The WHO Prequalification Programme does not specifically list paracetamol-caffeine combinations, but individual components must meet international pharmacopoeia standards. These include the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality, safety, and efficacy.

4India Regulatory Classification

In India, paracetamol-caffeine combinations are classified under Schedule H of the Drugs and Cosmetics Act, indicating that they are prescription-only medicines. The Drug Price Control Order (DPCO), enforced by the National Pharmaceutical Pricing Authority (NPPA), regulates the pricing of essential medicines. As of March 2026, paracetamol is under price control, but specific ceiling prices for paracetamol-caffeine combinations are not separately listed. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

Paracetamol and caffeine are well-established compounds with expired patents, allowing for generic competition. This has led to a competitive market with multiple manufacturers producing paracetamol-caffeine combinations. The absence of active patents facilitates the export of these combinations from India to various international markets without infringement concerns.

6Recent Industry Developments

In March 2026, the EMA initiated a PSUSA procedure (PSUSA/00002312/202506) for combinations including caffeine, codeine, paracetamol, and propyphenazone, reflecting ongoing pharmacovigilance efforts. (ema.europa.eu) In July 2025, the EMA published a list of nationally authorized medicinal products containing acetylsalicylic acid, caffeine, and paracetamol, indicating continued regulatory oversight. (ema.europa.eu) In June 2025, the UK's Food Standards Agency updated guidance for food business operators on food supplements containing caffeine, emphasizing the importance of accurate labeling and consumer safety. (food.gov.uk) In April 2025, the UK's Food Standards Agency provided guidance on the authorization requirements for extraction solvents, including those used in caffeine extraction, highlighting the need for compliance with safety standards. (food.gov.uk) In September 2024, the UK's Food Standards Agency issued advice on food supplements containing caffeine, focusing on consumer awareness and safe consumption practices. (food.gov.uk)

These developments underscore the dynamic regulatory environment surrounding paracetamol-caffeine combinations, necessitating continuous monitoring and compliance by exporters to ensure market access and consumer safety.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Paracetamol-caffeine

Retail & reference prices across 9 markets vs. India FOB export price of $2.39/unit

Global Price Benchmark for Paracetamol-caffeine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	Paracetamol-Caffeine combinations are available over-the-counter. The FDA regulates the safety and efficacy of these medications.
United Kingdom	$0.08	GBP	According to the NHS Drug Tariff, Paracetamol-Caffeine 500mg/65mg tablets are listed for reimbursement.
Germany	$0.09	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) includes Paracetamol-Caffeine combinations in its approved medicinal products.
Australia

Supply Chain Risk Assessment — Paracetamol-caffeine

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, renowned for its generic drug production, heavily relies on China for key starting materials (KSMs) essential in manufacturing active pharmaceutical ingredients (APIs). This dependency is particularly pronounced in the production of paracetamol and caffeine, the primary components of paracetamol-caffeine formulations. For instance, Farmson Pharmaceutical Guj Pvt Ltd, a leading Indian manufacturer, produces approximately 96.1 billion paracetamol tablets annually, underscoring the scale of production reliant on these raw materials. (ensun.io)

The COVID-19 pandemic in early 2020 exposed the vulnerabilities of this supply chain. Disruptions in Chinese manufacturing led to immediate shortages and price surges for essential drugs like paracetamol. This event highlighted the critical need for India to develop domestic capabilities in producing KSMs to mitigate future risks associated with external dependencies.

2Supplier Concentration & Single-Source Risk

Analysis of TransData Nexus's proprietary trade data from 2022 to 2026 reveals a significant concentration among Indian exporters of paracetamol-caffeine. The top five exporters account for 72.2% of total exports, with BASE PHARMACY INDIA alone contributing 48.2%. Such concentration poses a single-source risk, where disruptions affecting these key suppliers could severely impact the global supply chain.

Access Complete Paracetamol-caffeine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 118 transactions across 24 markets.

Request Demo View Pricing

Frequently Asked Questions — Paracetamol-caffeine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top paracetamol-caffeine exporters from India?

The leading paracetamol-caffeine exporters from India are BASE PHARMACY INDIA, COMBITIC GLOBAL CAPLET PRIVATE LIMITED, RONAK EXIM PRIVATE LIMITED, and 7 others. BASE PHARMACY INDIA leads with 48.2% market share ($666.7K). The top 5 suppliers together control 72.2% of total export value.

What is the total export value of paracetamol-caffeine from India?

The total export value of paracetamol-caffeine from India is $1.4M, recorded across 118 shipments from 31 active exporters to 24 countries. The average shipment value is $11.7K.

Which countries import paracetamol-caffeine from India?

India exports paracetamol-caffeine to 24 countries. The top importing countries are GHANA (51.9%), AFGHANISTAN (9.3%), SIERRA LEONE (6.4%), KENYA (6.4%), SOMALIA (5.1%), which together account for 79.1% of total export value.

What is the HS code for paracetamol-caffeine exports from India?

The primary HS code for paracetamol-caffeine exports from India is . This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Paracetamol-caffeine

Paracetamol-caffeine

How India Exports Paracetamol-caffeine to the World

Top Paracetamol-caffeine Exporters from India

Top Countries Importing Paracetamol-caffeine from India

Quick Facts

Related Combination Drugs

Related Analysis

Need Details?

Regulatory Landscape — Paracetamol-caffeine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Paracetamol-caffeine

Supply Chain Risk Assessment — Paracetamol-caffeine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Paracetamol-caffeine Trade Intelligence

Frequently Asked Questions — Paracetamol-caffeine Exports from India

Who are the top paracetamol-caffeine exporters from India?

What is the total export value of paracetamol-caffeine from India?

Which countries import paracetamol-caffeine from India?

What is the HS code for paracetamol-caffeine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of paracetamol-caffeine exports from India?

Which ports handle paracetamol-caffeine exports from India?

Why is India a leading exporter of paracetamol-caffeine?

What certifications do Indian paracetamol-caffeine exporters need?

How many buyers import paracetamol-caffeine from India?

What is the market share of the top paracetamol-caffeine exporter from India?

Analysis Methodology